Amelia Moncho
Medical · Edmond, OKNPI 1205803863
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 361 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 41 manufacturers, the largest accounting for just 20.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $1,788 and has fallen 54.4% since, to $816 in 2025. Among medical clinicians in OK with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 361 payments — averaging $18.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Pfizer$771
- GSK$653
- Novo Nordisk$539
- Lilly USA, LLC$421
- Corcept Therapeutics$348
- plus $3K from 35 others
What the payments were for
- Food & beverage$6,752100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$217
- EVENITY$124
- Wegovy$123
- Xience Sierra Coronary Stent$121
- INJECTAFER$120
- ZAVZPRET$107
- Korlym$103
How this compares
$6,752 in reported general payments places this provider in the 90th percentile of 370 medical providers in Oklahoma.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 47 | $55,662 |
| JardianceEmpagliflozin | 24 | $21,663 |
| OzempicSemaglutide | 18 | $16,316 |
| MyrbetriqMirabegron | 14 | $10,424 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 14 | $6,675 |
| Trokendi XrTopiramate | 12 | $5,670 |
| Nebivolol Hcl | 33 | $1,628 |
| Estradiol | 17 | $1,575 |
| Omeprazole | 19 | $1,270 |
| Montelukast Sodium | 12 | $1,188 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 22 | $851 |
| Aripiprazole | 13 | $849 |
| Atorvastatin Calcium | 51 | $711 |
| Pantoprazole Sodium | 29 | $695 |
| Levothyroxine Sodium | 28 | $409 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $421 | $55,66247 claims |
| Boehringer IngelheimJardiance | $81 | $21,66324 claims |
| Novo NordiskOzempic | $539 | $16,31618 claims |
| Astellas Pharma US IncMyrbetriq | $73 | $10,42414 claims |
| Supernus Pharmaceuticals, Inc.Trokendi Xr | $90 | $5,67012 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 370 medical providers in Oklahoma.
Other medical in Edmond
- Elizabeth MontgomeryEdmond$9K
- Amber WellmanEdmond$5K
- Crystal FredricksonEdmond$5K
- Bethany TrianaEdmond$4K
- Shannon MedleyEdmond$3K
- Karlee PfaffEdmond$3K
- Mebin ThomasOklahoma City$323K
- Kelle ChristiansonMidwest City$117K
- Kristine MurrowOklahoma City$81K
- Matthew DohlmanTulsa$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.